Application 075478
- Type
- ANDA
- Sponsor
- BARR
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORTREL 7/7/7 | ETHINYL ESTRADIOL; NORETHINDRONE | TABLET;ORAL-21 | 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG | No | No |
| 002 | NORTREL 7/7/7 | ETHINYL ESTRADIOL; NORETHINDRONE | TABLET;ORAL-28 | 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0555-9012 | Nortrel 7/7/7 | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9012 | Nortrel 7/7/7 | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9012 | Nortrel 7/7/7 | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9012 | Nortrel 7/7/7 | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 71205-685 | Nortrel 7/7/7 | Norethindrone and Ethinyl Estradiol | Proficient Rx LP | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 30905 | ORIG | 2004-06-10 |